GW Pharmaceuticals PLC (NASDAQ:GWPH)

136.96
BATS BZX Real-Time Price
As of 3:37pm ET
 -1.63 / -1.18%
Today’s Change
92.65
Today|||52-Week Range
143.37
+3.75%
Year-to-Date
Is a Beat in the Cards for Gilead (GILD) in Q1 Earnings?
11:42am / Zacks.com - Paid Partner Content
Want to Buy Marijuana Stocks? Check Out These 3 Charts
Apr 18 / Zacks.com - Paid Partner Content
What Lies Ahead for Vice ETFs?
Apr 23 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close138.59
Today’s open139.07
Day’s range136.81 - 139.10
Volume15,757
Average volume (3 months)411,154
Market cap$3.3B
Data as of 3:37pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-65.46%
Earnings growth (this year)-24.14%
Earnings growth (next 5 years)-50.35%
Revenue growth (last year)-28.45%
P/E ratioNM
Price/Sales246.06
Price/Book7.96

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...+3.76+2.43%
PBHPrestige Brands Hold...-0.18-0.56%
MDCOMedicines Co+1.59+5.60%
ICPTIntercept Pharmaceut...+3.86+5.84%
Data as of 3:37pm ET, 04/26/2018

Financials

Next reporting dateMay 7, 2018
EPS forecast (this quarter)-$2.22
Annual revenue (last year)$10.4M
Annual profit (last year)-$166.8M
Net profit margin-1,598.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts